Efficacy of the Canabrava/s Pupil Expansion Device in Cataract Surgery With Small Pupils: The First 30 Cases
Primary Purpose
Small Pupil, Cataract
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Cana's Ring
Sponsored by
About this trial
This is an interventional treatment trial for Small Pupil focused on measuring Small pupil
Eligibility Criteria
Inclusion Criteria:
- clinical indication for cataract surgery, age of at least 18 years, pupil diameter less than 5mm after dilation with phenylephrine and tropicamide, and lens with any degree of opacity.
Exclusion Criteria:
- eyes unable to perceive light during visual acuity testing, pupils with a diameter greater than 5mm and clear lenses
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Cana's Ring group
Arm Description
The device Cana's Ring was used during cataract surgery on these patients.
Outcomes
Primary Outcome Measures
Incidence of adverse events
Safety of the material of the device from break, lesion of eye structures and iritis
Secondary Outcome Measures
Stability of the device during surgery
Evaluate whether the device remains stable and attached to the iris during the entire surgery
Full Information
NCT ID
NCT03206983
First Posted
May 18, 2017
Last Updated
June 29, 2017
Sponsor
Santa Casa de Misericórdia de Belo Horizonte
1. Study Identification
Unique Protocol Identification Number
NCT03206983
Brief Title
Efficacy of the Canabrava/s Pupil Expansion Device in Cataract Surgery With Small Pupils: The First 30 Cases
Official Title
Efficacy of the Canabrava/s Pupil Expansion Device in Cataract Surgery With Small Pupils: The First 30 Cases
Study Type
Interventional
2. Study Status
Record Verification Date
June 2017
Overall Recruitment Status
Completed
Study Start Date
September 2014 (Actual)
Primary Completion Date
September 2016 (Actual)
Study Completion Date
September 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Santa Casa de Misericórdia de Belo Horizonte
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To evaluate the intraoperative stability, safety and overall efficacy of the Canabrava Ring (AJL - SPAIN) when used to expand pupils with less diameter than 5 mm and pupils with sphincter synechiae.
Detailed Description
In this consecutive case series, 30 eyes of 29 patients underwent cataract surgery using a new disposable small-pupil expansion device, Canabrava's Ring (AJL Ophthalmic, Spain). It is the first iris expansion ring produced with indents that do not align with each other in the superior and inferior regions, resulting in a small vertical length (0.4mm) that minimizes risk of endothelial contact. All eyes had poorly preoperatively dilated pupils of less than 5mm. Fifteen eyes had significant infective or traumatic pathology preoperatively. Vertical and horizontal pupil diameters were evaluated pre-, intra- and 1 month postoperatively, and were used to calculate pupil circumference. Intraoperative and postoperative pupil circumference comprised the primary outcomes of interest.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Small Pupil, Cataract
Keywords
Small pupil
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
29 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cana's Ring group
Arm Type
Experimental
Arm Description
The device Cana's Ring was used during cataract surgery on these patients.
Intervention Type
Device
Intervention Name(s)
Cana's Ring
Intervention Description
The device is used during cataract surgery to help dilate small pupils (under 5mm)
Primary Outcome Measure Information:
Title
Incidence of adverse events
Description
Safety of the material of the device from break, lesion of eye structures and iritis
Time Frame
30 days after surgery
Secondary Outcome Measure Information:
Title
Stability of the device during surgery
Description
Evaluate whether the device remains stable and attached to the iris during the entire surgery
Time Frame
During surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
clinical indication for cataract surgery, age of at least 18 years, pupil diameter less than 5mm after dilation with phenylephrine and tropicamide, and lens with any degree of opacity.
Exclusion Criteria:
eyes unable to perceive light during visual acuity testing, pupils with a diameter greater than 5mm and clear lenses
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sergio Canabrava, MD
Organizational Affiliation
Santa Casa de Misericórdia de Belo Horizonte
Official's Role
Study Chair
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Efficacy of the Canabrava/s Pupil Expansion Device in Cataract Surgery With Small Pupils: The First 30 Cases
We'll reach out to this number within 24 hrs